Interest Expense in USD of ABVC BIOPHARMA, INC. from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
ABVC BIOPHARMA, INC. quarterly/annual Interest Expense history and change rate from Q2 2010 to Q1 2024.
  • ABVC BIOPHARMA, INC. Interest Expense for the quarter ending 31 Mar 2024 was $182K, a 221% increase year-over-year.
  • ABVC BIOPHARMA, INC. Interest Expense for the twelve months ending 31 Mar 2024 was $1.44M, a 333% increase year-over-year.
  • ABVC BIOPHARMA, INC. annual Interest Expense for 2023 was $1.31M, a 347% increase from 2022.
  • ABVC BIOPHARMA, INC. annual Interest Expense for 2022 was $294K, a 29.4% increase from 2021.
  • ABVC BIOPHARMA, INC. annual Interest Expense for 2021 was $227K, a 43.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.44M $182K +$125K +221% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 $1.31M -$76.4K -$211K -157% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 $1.52M $1.22M +$1.09M +863% 01 Jul 2023 30 Sep 2023 10-Q 15 Nov 2023
Q2 2023 $432K $115K +$100K +678% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $332K $56.7K +$38.5K +211% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q4 2022 $294K $134K +$159K 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 $135K $127K +$87.9K +227% 01 Jul 2022 30 Sep 2022 10-Q 15 Nov 2023
Q2 2022 $47.3K $14.8K -$67.9K -82.1% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $115K $18.2K -$112K -86% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $227K -$24.4K -$141K -121% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $368K $38.7K +$22.4K +137% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $346K $82.7K -$57.9K -41.2% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $404K $130K -$1.29K -0.98% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $405K $117K +$9.21K +8.57% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $396K $16.3K -$95.7K -85.4% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $491K $141K +$7.84K +5.91% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $484K $132K +$1.63K +1.26% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 $482K $107K -$9.3K -7.96% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 $491K $112K -$10.4K -8.47% 01 Jul 2019 30 Sep 2019 10-Q 17 Nov 2020
Q2 2019 $502K $133K +$15.9K +13.6% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 $486K $130K +$23K +21.6% 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020
Q4 2018 $463K $117K +$88.3K +310% 01 Oct 2018 31 Dec 2018 10-K 15 May 2020
Q3 2018 $374K $122K +$94.9K +345% 01 Jul 2018 30 Sep 2018 10-Q 18 Nov 2019
Q2 2018 $280K $117K +$88.3K +310% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 $191K $107K +$87.9K +462% 01 Jan 2018 31 Mar 2018 10-Q 28 May 2019
Q4 2017 $103K $28.5K 01 Oct 2017 31 Dec 2017 10-KT 13 Apr 2018
Q3 2017 $27.5K 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $28.5K +$24.7K +659% 01 Apr 2017 30 Jun 2017 10-Q 20 Aug 2018
Q1 2017 $19K 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q2 2016 $3.75K +$3.75K 01 Apr 2016 30 Jun 2016 10-Q 19 Mar 2018
Q3 2015 $0 $0 $0 01 Jul 2015 30 Sep 2015 10-K 27 Nov 2015
Q2 2015 $0 $0 $0 01 Apr 2015 30 Jun 2015 10-Q 19 Aug 2015
Q1 2015 $0 $0 $0 01 Jan 2015 31 Mar 2015 10-Q 05 Jun 2015
Q4 2014 $0 $0 $0 01 Oct 2014 31 Dec 2014 10-Q 17 Apr 2015
Q3 2014 $0 $0 19 Sep 2014 30 Sep 2014 10-K 27 Nov 2015
Q2 2014 $0 $0 -$16.5K -100% 01 Apr 2014 30 Jun 2014 10-Q 19 Aug 2015
Q1 2014 $16.5K $0 -$16.2K -100% 01 Jan 2014 31 Mar 2014 10-Q 05 Jun 2015
Q4 2013 $32.7K $0 -$16.4K -100% 01 Oct 2013 31 Dec 2013 10-Q 17 Apr 2015
Q3 2013 $49.1K $0 -$14.9K -100% 01 Jul 2013 30 Sep 2013 10-K 16 Apr 2015
Q2 2013 $64K $16.5K +$3.04K +22.5% 01 Apr 2013 30 Jun 2013 10-Q 17 Apr 2015
Q1 2013 $61K $16.2K +$3.9K +31.7% 01 Jan 2013 31 Mar 2013 10-Q 17 Apr 2015
Q4 2012 $57.1K $16.4K -$30.6K -65.1% 01 Oct 2012 31 Dec 2012 10-Q 17 Apr 2015
Q3 2012 $87.7K $14.9K -$265K -94.7% 01 Jul 2012 30 Sep 2012 10-K 16 Apr 2015
Q2 2012 $353K $13.5K -$29.1K -68.3% 01 Apr 2012 30 Jun 2012 10-Q 16 Apr 2015
Q1 2012 $382K $12.3K +$73.7K 01 Jan 2012 31 Mar 2012 10-Q 16 Apr 2015
Q4 2011 $308K $47K +$103K 01 Oct 2011 31 Dec 2011 10-Q 16 Apr 2015
Q3 2011 $205K $280K 01 Jul 2011 30 Sep 2011 10-K 15 Apr 2015
Q2 2011 $42.6K +$105K 01 Apr 2011 30 Jun 2011 10-Q/A 20 Aug 2012
Q1 2011 -$61.4K 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q4 2010 -$56.5K 01 Oct 2010 31 Dec 2010 10-Q 21 Feb 2012
Q2 2010 -$62K 01 Apr 2010 30 Jun 2010 10-Q/A 08 Sep 2011

ABVC BIOPHARMA, INC. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.31M +$1.02M +347% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 $294K +$66.8K +29.4% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024
2021 $227K -$178K -43.9% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 $405K -$77K -16% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $482K +$19.3K +4.16% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 $463K +$359K +347% 01 Jan 2018 31 Dec 2018 10-K 15 May 2020
2017 $103K +$93.3K +917% 01 Jan 2017 31 Dec 2017 10-K 15 Apr 2019
2016 $10.2K +$10.2K 01 Oct 2015 30 Sep 2016 10-KT 13 Apr 2018
2015 $0 $0 01 Oct 2014 30 Sep 2015 10-K 27 Nov 2015
2014 $0 -$49.1K -100% 01 Oct 2013 18 Sep 2014 10-K 27 Nov 2015
2013 $49.1K -$38.6K -44% 01 Oct 2012 30 Sep 2013 10-K 16 Apr 2015
2012 $87.7K -$117K -57.2% 01 Oct 2011 30 Sep 2012 10-K 16 Apr 2015
2011 $205K +$423K 01 Oct 2010 30 Sep 2011 10-K 15 Apr 2015
2010 -$219K 01 Oct 2009 30 Sep 2010 10-K/A 28 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.